Pharming Group N.V. provided revenue guidance for 2024. For the period, the company expects total revenues between USD280 million and USD295 million (14% to 20% growth), with quarterly fluctuations expected.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.845 EUR | -1.63% | -4.20% | -18.04% |
May. 08 | Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Pharming Group N.V. Provides Revenue Guidance for 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.04% | 619M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Group N.V. Provides Revenue Guidance for 2024